Manuel de Oliveira-Santos1, Miguel Castelo-Branco2, Rodolfo Silva3, Andreia Gomes3, Nuno Chichorro2, Antero Abrunhosa2, Paulo Donato2, João Pedroso de Lima4, Mariano Pego5, Lino Gonçalves4, Maria João Ferreira6. 1. University Hospitals of Coimbra, Cardiology, Praceta Prof. Mota Pinto, 3000-075, Coimbra, Portugal; Institute of Nuclear Sciences Applied to Health - Faculty of Medicine of the University of Coimbra, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal; Faculty of Medicine of the University of Coimbra, Rua Larga, 3004-504, Coimbra, Portugal. Electronic address: oliveirasantos@uc.pt. 2. Institute of Nuclear Sciences Applied to Health - Faculty of Medicine of the University of Coimbra, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal; Faculty of Medicine of the University of Coimbra, Rua Larga, 3004-504, Coimbra, Portugal. 3. Institute of Nuclear Sciences Applied to Health - Faculty of Medicine of the University of Coimbra, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal. 4. Faculty of Medicine of the University of Coimbra, Rua Larga, 3004-504, Coimbra, Portugal. 5. University Hospitals of Coimbra, Cardiology, Praceta Prof. Mota Pinto, 3000-075, Coimbra, Portugal. 6. University Hospitals of Coimbra, Cardiology, Praceta Prof. Mota Pinto, 3000-075, Coimbra, Portugal; Institute of Nuclear Sciences Applied to Health - Faculty of Medicine of the University of Coimbra, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal; Faculty of Medicine of the University of Coimbra, Rua Larga, 3004-504, Coimbra, Portugal.
Abstract
BACKGROUND AND AIMS: Atherosclerotic plaque molecular imaging with 18F-sodium fluoride (NaF) in positron emission tomography with computed tomography (PET-CT) provides potential discrimination between active unstable microcalcification and established dormant calcification. We aimed to study 18F-NaF atherosclerotic plaque uptake in high cardiovascular (CV) risk participants and its associations with CV risk factors, coronary calcium score and thoracic fat volume. METHODS: High CV risk hypertensive individuals from a single centre were prospectively scanned with 18F-NaF-PET-CT in the coronary, aortic and carotideal arteries. Atherosclerotic plaque 18F-NaF uptake was expressed as Corrected Uptake per Lesion (CUL): maximum standard uptake value in each vascular territory subtracted by mean blood pool activity. RESULTS: Mean age was 64 years, 56% male and 96% Caucasian (n = 25). Ninety six per cent of the subjects showed 18F-NaF uptake in the aorta (CUL 0.9 ± 0.3), 40% in the carotid arteries (median CUL 0.0, IQR 0.0-0.7) and 64% in the coronary arteries (0.4, IQR 0.0-0.6). Individuals with ≥ five risk factors (60%) had increased overall 18F-NaF uptake (1.1 ± 0.3 vs. 0.7 ± 0.3, p < 0.01), which was positively correlated with predicted fatal CV risk - SCORE (r = 0.49, p = 0.01). There was no correlation between 18F-NaF uptake in the coronary arteries and calcium score (p = 0.87). Thoracic fat was moderately correlated with overall CUL (r = 0.41, p = 0.04). CONCLUSIONS: In a high CV risk group, 18F-NaF atherosclerotic plaque uptake was related to the burden of CV risk factors and thoracic fat volume, but there was no association between coronary uptake and calcium score.
BACKGROUND AND AIMS: Atherosclerotic plaque molecular imaging with 18F-sodium fluoride (NaF) in positron emission tomography with computed tomography (PET-CT) provides potential discrimination between active unstable microcalcification and established dormant calcification. We aimed to study 18F-NaF atherosclerotic plaque uptake in high cardiovascular (CV) risk participants and its associations with CV risk factors, coronary calcium score and thoracic fat volume. METHODS: High CV risk hypertensive individuals from a single centre were prospectively scanned with 18F-NaF-PET-CT in the coronary, aortic and carotideal arteries. Atherosclerotic plaque 18F-NaF uptake was expressed as Corrected Uptake per Lesion (CUL): maximum standard uptake value in each vascular territory subtracted by mean blood pool activity. RESULTS: Mean age was 64 years, 56% male and 96% Caucasian (n = 25). Ninety six per cent of the subjects showed 18F-NaF uptake in the aorta (CUL 0.9 ± 0.3), 40% in the carotid arteries (median CUL 0.0, IQR 0.0-0.7) and 64% in the coronary arteries (0.4, IQR 0.0-0.6). Individuals with ≥ five risk factors (60%) had increased overall 18F-NaF uptake (1.1 ± 0.3 vs. 0.7 ± 0.3, p < 0.01), which was positively correlated with predicted fatal CV risk - SCORE (r = 0.49, p = 0.01). There was no correlation between 18F-NaF uptake in the coronary arteries and calcium score (p = 0.87). Thoracic fat was moderately correlated with overall CUL (r = 0.41, p = 0.04). CONCLUSIONS: In a high CV risk group, 18F-NaF atherosclerotic plaque uptake was related to the burden of CV risk factors and thoracic fat volume, but there was no association between coronary uptake and calcium score.
Authors: Jacek Kwiecinski; Daniel S Berman; Sang-Eun Lee; Damini Dey; Sebastien Cadet; Martin L Lassen; Guido Germano; Maurits A Jansen; Marc R Dweck; David E Newby; Hyuk-Jae Chang; Mijin Yun; Piotr J Slomka Journal: J Nucl Med Date: 2018-09-13 Impact factor: 10.057
Authors: Jacek Kwiecinski; Philip D Adamson; Martin L Lassen; Mhairi K Doris; Alastair J Moss; Sebastian Cadet; Maurits A Jansen; Damini Dey; Sang-Eun Lee; Mijin Yun; Hyuk-Jae Chang; Marc R Dweck; David E Newby; Daniel S Berman; Piotr J Slomka Journal: Circ Cardiovasc Imaging Date: 2018-12 Impact factor: 7.792
Authors: Daniele Massera; Mhairi K Doris; Sebastien Cadet; Jacek Kwiecinski; Tania A Pawade; Frederique E C M Peeters; Damini Dey; David E Newby; Marc R Dweck; Piotr J Slomka Journal: J Nucl Cardiol Date: 2018-11-29 Impact factor: 5.952
Authors: Csilla Celeng; Bart de Keizer; Béla Merkely; Pim de Jong; Tim Leiner; Richard A P Takx Journal: Curr Cardiol Rep Date: 2018-02-12 Impact factor: 2.931